Table 1. Acute Myeloid Leukemia Biomarker Detection Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Acute Myeloid Leukemia Biomarker Detection Market Restraints

Table 3. Acute Myeloid Leukemia Biomarker Detection Market Trends

Table 4. Acute Myeloid Leukemia Biomarker Detection Industry Policy

Table 5. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024, US$ million

Table 6. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company, 2019-2024

Table 7. Global Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share by Company, 2019-2024

Table 9. Global Acute Myeloid Leukemia Biomarker Detection Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Acute Myeloid Leukemia Biomarker Detection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Acute Myeloid Leukemia Biomarker Detection Mergers & Acquisitions, Expansion Plans

Table 12. Global Acute Myeloid Leukemia Biomarker Detection Manufacturers Product Type

Table 13. China Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024, US$ million

Table 14. China Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company, 2019-2024

Table 15. China Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Acute Myeloid Leukemia Biomarker Detection Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Acute Myeloid Leukemia Biomarker Detection Import & Export Trends

Table 19. Main Sources of China Acute Myeloid Leukemia Biomarker Detection Import

Table 20. Export Destination of China Acute Myeloid Leukemia Biomarker Detection

Table 21. Global Headquarters and Manufacturing Base of Acute Myeloid Leukemia Biomarker Detection Manufacturers

Table 22. Global Major Manufacturers, Acute Myeloid Leukemia Biomarker Detection Capacity Expansion and Future Plans

Table 23. Global Acute Myeloid Leukemia Biomarker Detection Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Acute Myeloid Leukemia Biomarker Detection Production by Region, 2019-2024, (K Units)

Table 25. Global Acute Myeloid Leukemia Biomarker Detection Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Acute Myeloid Leukemia Biomarker Detection Upstream (Raw Materials)

Table 27. Global Acute Myeloid Leukemia Biomarker Detection Typical Customers

Table 28. Acute Myeloid Leukemia Biomarker Detection Typical Distributors

Table 29. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Acute Myeloid Leukemia Biomarker Detection Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Table 37. By Country, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Table 39. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 40. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 41. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Abbott Laboratories Company Profile and Main Business

Table 43. Abbott Laboratories Recent Developments

Table 44. Bio-Rad Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 46. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Bio-Rad Laboratories, Inc. Company Profile and Main Business

Table 48. Bio-Rad Laboratories, Inc. Recent Developments

Table 49. Genmark Saghlk Orinleri Company Information, Head Office, Market Area and Industry Position

Table 50. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 51. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Genmark Saghlk Orinleri Company Profile and Main Business

Table 53. Genmark Saghlk Orinleri Recent Developments

Table 54. Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position

Table 55. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 56. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Laboratory Corporation of America Holdings Company Profile and Main Business

Table 58. Laboratory Corporation of America Holdings Recent Developments

Table 59. Danaher Company Information, Head Office, Market Area and Industry Position

Table 60. Danaher Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 61. Danaher Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Danaher Company Profile and Main Business

Table 63. Danaher Recent Developments

Table 64. Medaysis Company Company Information, Head Office, Market Area and Industry Position

Table 65. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 66. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Medaysis Company Company Profile and Main Business

Table 68. Medaysis Company Recent Developments

Table 69. NeoGenomics Laboratories Company Information, Head Office, Market Area and Industry Position

Table 70. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 71. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. NeoGenomics Laboratories Company Profile and Main Business

Table 73. NeoGenomics Laboratories Recent Developments

Table 74. QIAGEN N.V. Company Information, Head Office, Market Area and Industry Position

Table 75. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 76. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. QIAGEN N.V. Company Profile and Main Business

Table 78. QIAGEN N.V. Recent Developments

Table 79. Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position

Table 80. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 81. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Thermo Fisher Scientific, Inc. Company Profile and Main Business

Table 83. Thermo Fisher Scientific, Inc. Recent Developments

Table 84. GeneTex Company Information, Head Office, Market Area and Industry Position

Table 85. GeneTex Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 86. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. GeneTex Company Profile and Main Business

Table 88. GeneTex Recent Developments

List of Figure

Figure 1. Acute Myeloid Leukemia Biomarker Detection Picture

Figure 2. By Revenue, Global Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Acute Myeloid Leukemia Biomarker Detection Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Share of Global Market, 2019-2030

Figure 10. Global Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Acute Myeloid Leukemia Biomarker Detection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Acute Myeloid Leukemia Biomarker Detection Domestic VS Export, 2022

Figure 16. Global Acute Myeloid Leukemia Biomarker Detection Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Acute Myeloid Leukemia Biomarker Detection Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Acute Myeloid Leukemia Biomarker Detection Production Market Share & Forecast by Region, 2019-2030

Figure 19. Acute Myeloid Leukemia Biomarker Detection Industry Chain

Figure 20. Acute Myeloid Leukemia Biomarker Detection Procurement Model

Figure 21. Acute Myeloid Leukemia Biomarker Detection Sales Model

Figure 22. Acute Myeloid Leukemia Biomarker Detection Sales Channels, Direct Sales and Distribution

Figure 23. Next Generation Sequencing Technology

Figure 24. PCR Detection Technology

Figure 25. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 27. By Type, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Research Institutions

Figure 32. Other

Figure 33. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 35. By Application, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 39. By Region, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 40. North America Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 42. Europe Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 44. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 46. South America Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 48. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 51. By Type, U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 55. By Type, Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 57. China Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 59. By Type, China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 63. By Type, Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 67. By Type, South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 71. By Type, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 73. India Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 75. By Type, India Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 79. By Type, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches